Related by context. Frequent words. (Click for all words.) 61 ACRIN 61 Gynecologic Oncology Group 58 Phase Ib clinical 57 metastatic castration resistant 56 axitinib 56 dutasteride 55 pertuzumab 55 NSABP 55 randomized Phase III 55 pharmacokinetic PK 55 forodesine 55 substudy 55 APTIVUS 55 subanalysis 54 J Clin Endocrinol Metab 54 Phase III Clinical Trial 54 PREVAIL 54 Prostate Cancer Patients 54 Heart Failure Trial 54 Molecular Cancer 54 Gastric Cancer 54 elotuzumab 54 tesmilifene 54 olaparib 54 Radiation Therapy Oncology 54 EORTC 54 Phase 1b trial 54 enzastaurin 54 Arch Intern Med 53 phase IIa clinical 53 Prostate Cancer Risk 53 SABCS 53 ALLHAT 53 multicenter Phase 53 prospective observational 53 Clinical Trial Results 53 MADIT CRT 53 www.syntapharma.com 53 phase IIb 53 elevated LDL cholesterol 53 Thrombolysis 53 CCX# 53 Venous Thromboembolism 53 Phase 2a trial 53 fluvastatin 53 multicenter clinical 53 e# [005] 53 pharmacodynamic effects 53 prospectively defined 53 Am J Pathol 53 RTOG 53 bone metastasis 53 phase IIb clinical 53 National Surgical Adjuvant 53 Meta Analysis 53 JAMA. 53 subgroup analyzes 52 Pivotal Trial 52 Arch Neurol 52 placebo controlled clinical 52 Randomized controlled 52 Azedra 52 Multicenter 52 Patient Registry 52 Ixempra 52 SPIRIT IV 52 ACCLAIM 52 J Am Coll 52 Pivotal Phase 52 Preclinical Data 52 placebo controlled Phase 52 Atherosclerosis Risk 52 J Clin Oncol 52 Glioma 52 CAPRISA 52 Response Evaluation Criteria 52 talabostat 52 PRECiSE 52 PROVE IT 52 Am J Epidemiol 52 Phase III randomized 51 TRITON TIMI 51 phase IIa 51 abiraterone acetate 51 Metastatic Melanoma 51 candesartan 51 Health Initiative WHI 51 Patient Enrollment 51 deforolimus 51 prospective multicenter 51 #:#-# [033] 51 neoadjuvant 51 HPV# 51 Dasatinib 51 drug conjugate 51 irbesartan 51 colorectal carcinoma 51 registrational trial 51 multicenter randomized double 51 goserelin 51 retrospective cohort study